284 related articles for article (PubMed ID: 16900525)
41. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
[TBL] [Abstract][Full Text] [Related]
42. [Trophoblastic diseases].
ten Kate-Booij MJ; Lok CA; Verheijen RH; Massuger LF; van Trommel NE
Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2219-24. PubMed ID: 19009808
[TBL] [Abstract][Full Text] [Related]
43. Treatment of metastatic gestational choriocarcinoma with oral methotrexate in a combat environment.
Farley JH; Heathcock RB; Branch W; Larsen W; Homas D
Obstet Gynecol; 2005 May; 105(5 Pt 2):1250-4. PubMed ID: 15863599
[TBL] [Abstract][Full Text] [Related]
44. Salvage chemotherapy for high-risk gestational trophoblastic tumor.
Matsui H; Iitsuka Y; Suzuka K; Yamazawa K; Mitsuhashi A; Sekiya S
J Reprod Med; 2004 Jun; 49(6):438-42. PubMed ID: 15283050
[TBL] [Abstract][Full Text] [Related]
45. Assessment of the response to chemotherapy in gestational trophoblastic neoplasia with vaginal metastases.
Ghaemmaghami F; Behroozi S; Mousavi A; Ashrafgangooei T; Gilani MM; Behtash N; Ghanbari Z
Arch Gynecol Obstet; 2008 Oct; 278(4):315-8. PubMed ID: 18293004
[TBL] [Abstract][Full Text] [Related]
46. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
Dobson LS; Lorigan PC; Coleman RE; Hancock BW
Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722
[TBL] [Abstract][Full Text] [Related]
47. Gestational trophoblastic tumor with liver metastasis after misoprostol abortion.
Mousavi SA; Behnamfar F
Arch Gynecol Obstet; 2009 Apr; 279(4):587-90. PubMed ID: 18762963
[TBL] [Abstract][Full Text] [Related]
48. Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet.
Osborne R; Covens A; Mirchandani D; Gerulath A
J Reprod Med; 2004 Aug; 49(8):655-61. PubMed ID: 15457856
[TBL] [Abstract][Full Text] [Related]
49. Response to initial treatment of low and intermediate risk gestational trophoblastic disease with methotrexate and folinic acid.
Tonanont M; Inthasorn P; Boriboonhirunsarn D; Wongthiraporn W; Suphanit I
J Med Assoc Thai; 2005 Oct; 88(10):1349-54. PubMed ID: 16519378
[TBL] [Abstract][Full Text] [Related]
50. Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?
Miller CR; Chappell NP; Sledge C; Leath CA; Phippen NT; Havrilesky LJ; Barnett JC
Gynecol Oncol; 2017 Jan; 144(1):125-129. PubMed ID: 27816248
[TBL] [Abstract][Full Text] [Related]
51. Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance?
Kohorn EI
Gynecol Oncol; 2002 Apr; 85(1):36-9. PubMed ID: 11925117
[TBL] [Abstract][Full Text] [Related]
52. Chemotherapy regimens used in the treatment of gestational trophoblastic neoplasia at Philippine General Hospital: treatment outcomes and toxicity.
Cagayan MS; Gacoba MC
J Reprod Med; 2006 Nov; 51(11):907-18. PubMed ID: 17165439
[TBL] [Abstract][Full Text] [Related]
53. Dactinomycin in the treatment of recurrent or persistent endometrial carcinoma: A Phase II study of the Gynecologic Oncology Group.
Moore DH; Blessing JA; Dunton C; Buller RE; Reid GC
Gynecol Oncol; 1999 Dec; 75(3):473-5. PubMed ID: 10600310
[TBL] [Abstract][Full Text] [Related]
54. Management of patients with metastatic gestational trophoblastic tumor.
Ghaemmaghami F; Behtash N; Soleimani K; Hanjani P
Gynecol Oncol; 2004 Jul; 94(1):187-90. PubMed ID: 15262140
[TBL] [Abstract][Full Text] [Related]
55. Methotrexate, bleomycin, and Etoposide in the treatment of gestational trophoblastic neoplasia.
Ngan HY; Tam KF; Lam KW; Chan KK
Obstet Gynecol; 2006 May; 107(5):1012-7. PubMed ID: 16648404
[TBL] [Abstract][Full Text] [Related]
56. What we know about low-level hCG: definition, classification and management.
Kohorn EI
J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of the FAEV regimen in the treatment of high-risk, drug-resistant gestational trophoblastic tumor.
Wan X; Xiang Y; Yang X; Wu Y; Liu N; Chen L; Dong R
J Reprod Med; 2007 Oct; 52(10):941-4. PubMed ID: 17977170
[TBL] [Abstract][Full Text] [Related]
58. [Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
Xiang Y; Wan XR; Sun ZJ; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):79-82. PubMed ID: 15840283
[TBL] [Abstract][Full Text] [Related]
59. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
Ngan HY; Wong LC
Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563
[TBL] [Abstract][Full Text] [Related]
60. Practical issues in the management of low-risk gestational trophoblast tumors.
Savage P; Seckl M; Short D
J Reprod Med; 2008 Oct; 53(10):774-80. PubMed ID: 19004403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]